Agenus Inc

AGEN · Moat type: REGULIERUNG

MoatScore

0/10

Fair Value

n/a

Margin of Safety

n/a

Rating

MEIDEN

GESCHÄFTSMODELL Agenus Inc. is a biotechnology company specialized in the development and licensing of immuno-oncology therapies—particularly checkpoint inhibitors and bispecific antibodies—and generates revenue primarily through licensing fees, milestone payments, and the sale of antibody reagents.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.